(19)
(11) EP 2 651 304 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.07.2020 Bulletin 2020/29

(45) Mention of the grant of the patent:
27.05.2020 Bulletin 2020/22

(21) Application number: 11794179.9

(22) Date of filing: 13.12.2011
(51) International Patent Classification (IPC): 
A61B 7/04(2006.01)
 G06F 17/00(2019.01)
(86) International application number:
PCT/EP2011/072537
(87) International publication number:
WO 2012/080209 (21.06.2012 Gazette 2012/25)

(54)

SYSTEM, STETHOSCOPE AND METHOD FOR INDICATING RISK OF CORONARY ARTERY DISEASE

SYSTEM, STETHOSKOP UND VERFAHREN ZUR ANZEIGE DES RISIKOS EINER KORONARARTERIENERKRANKUNG

SYSTÈME, STÉTHOSCOPE ET PROCÉDÉ POUR INDIQUER LE RISQUE D'UNE CORONAROPATHIE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 13.12.2010 EP 10194756

(43) Date of publication of application:
23.10.2013 Bulletin 2013/43

(60) Divisional application:
20168782.9

(73) Proprietor: Acarix A/S
2900 Hellerup (DK)

(72) Inventors:
  • SCHMIDT, Samuel, Emil
    9210 Aalborg Sö (DK)
  • STRUIJK, Johannes, Jan
    9575 Terndrup (DK)

(74) Representative: Brann AB 
P.O. Box 3690 Drottninggatan 27
103 59 Stockholm
103 59 Stockholm (SE)


(56) References cited: : 
US-A- 5 109 863
US-A- 6 048 319
 US-A- 5 638 823
US-A1- 2009 177 107
   
  • GAUTHIER D ET AL: "Spectral Analysis of Heart Sounds Associated With Coronary Occlusions", INFORMATION TECHNOLOGY APPLICATIONS IN BIOMEDICINE, 2007. ITAB 2007. 6 TH INTERNATIONAL SPECIAL TOPIC CONFERENCE ON, IEEE, PI, 8 November 2007 (2007-11-08), pages 49-52, XP031338941, ISBN: 978-1-4244-1867-1
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).